CoChat

The Prophylactic Effect of Probiotic Enterococcus lactis IW5 against Different Human Cancer Cells

Open access
Nami, Yousef, Haghshenas, Babak, Haghshenas, Minoo, Abdullah, Norhafizah, Yari Khosroushahi, Ahmad · 2015 · Frontiers in Microbiology
Cited by 88

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Enterococcus lactis IW5 was obtained from human gut and the potential probiotic characteristics of this organism were then evaluated. Results showed that this strain was highly resistant to low pH and high bile salt and adhered strongly to Caco-2 human epithelial colorectal cell lines. The supernatant of E. lactis IW5 strongly inhibited the growth of several pathogenic bacteria and decreased the viability of different cancer cells, such as HeLa, MCF-7, AGS, HT-29, and Caco-2. Conversely, E. lactis IW5 did not inhibit the viability of normal FHs-74 cells. This strain did not generate toxic enzymes, including β-glucosidase, β-glucuronidase, and N-acetyl-β-glucosaminidase and was highly susceptible to ampicillin, gentamycin, penicillin, vancomycin, clindamycin, sulfamethoxazol, and chloramphenicol but resistant to erythromycin and tetracyclin. This study provided evidence for the effect of E. lactis IW5 on cancer cells. Therefore, E. lactis IW5, as a bioactive therapeutics, should be subjected to other relevant tests to verify the therapeutic suitability of this strain for clinical applications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmicb.2015.01317

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 88

Metadata

Authors
Nami, Y., Haghshenas, B., Haghshenas, M., Abdullah, N., & Yari Khosroushahi, A.
Venue
Frontiers in Microbiology
Published
2015-11-26
Volume
6
Pages
1317-1317
ISSN
1664-302X (ISSN-L)
OpenAlex
W2176033230
Cited by
88
References
3
FWCI
5.85
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Prophylactic Effect of Probiotic Enterococcus lactis IW5 against Different Human Cancer Cells. https://app.cochat.ai/papers/10.3389/fmicb.2015.01317
The paper
Nami, Y., Haghshenas, B., Haghshenas, M., Abdullah, N., & Yari Khosroushahi, A. (2015). The Prophylactic Effect of Probiotic Enterococcus lactis IW5 against Different Human Cancer Cells. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2015.01317

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.